Barclays
PFE icon

Barclays’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$378M Buy
15,575,088
+656,946
+4% +$15.9M 0.09% 119
2025
Q1
$378M Sell
14,918,142
-1,962,267
-12% -$49.7M 0.11% 120
2024
Q4
$448M Sell
16,880,409
-10,203,305
-38% -$271M 0.13% 87
2024
Q3
$784M Buy
27,083,714
+11,840,905
+78% +$343M 0.21% 49
2024
Q2
$426M Sell
15,242,809
-6,322,497
-29% -$177M 0.13% 102
2024
Q1
$598M Buy
21,565,306
+9,939,752
+85% +$276M 0.21% 73
2023
Q4
$335M Sell
11,625,554
-4,503,233
-28% -$130M 0.12% 113
2023
Q3
$535M Buy
16,128,787
+3,102,892
+24% +$103M 0.33% 54
2023
Q2
$478M Buy
13,025,895
+6,466,670
+99% +$237M 0.3% 64
2023
Q1
$268M Sell
6,559,225
-5,941,259
-48% -$242M 0.12% 73
2022
Q4
$641M Buy
12,500,484
+3,310,499
+36% +$170M 0.29% 29
2022
Q3
$402M Buy
9,189,985
+1,993,130
+28% +$87.2M 0.44% 35
2022
Q2
$377M Sell
7,196,855
-4,125,023
-36% -$216M 0.23% 44
2022
Q1
$586M Sell
11,321,878
-3,779,832
-25% -$196M 0.46% 36
2021
Q4
$892M Buy
15,101,710
+574,305
+4% +$33.9M 0.33% 34
2021
Q3
$625M Buy
14,527,405
+4,470,323
+44% +$192M 0.28% 40
2021
Q2
$394M Buy
10,057,082
+1,459,377
+17% +$57.1M 0.19% 58
2021
Q1
$311M Sell
8,597,705
-463,591
-5% -$16.8M 0.17% 66
2020
Q4
$334M Sell
9,061,296
-5,206,772
-36% -$192M 0.18% 53
2020
Q3
$524M Buy
14,268,068
+5,833,187
+69% +$214M 0.31% 24
2020
Q2
$276M Buy
8,434,881
+34,450
+0.4% +$1.13M 0.21% 40
2020
Q1
$274M Sell
8,400,431
-4,467,374
-35% -$146M 0.22% 33
2019
Q4
$504M Sell
12,867,805
-83,392
-0.6% -$3.27M 0.28% 33
2019
Q3
$465M Sell
12,951,197
-851,292
-6% -$30.6M 0.29% 22
2019
Q2
$598M Sell
13,802,489
-870,915
-6% -$37.7M 0.37% 21
2019
Q1
$623M Buy
14,673,404
+1,299,086
+10% +$55.2M 0.43% 14
2018
Q4
$584M Sell
13,374,318
-827,042
-6% -$36.1M 0.45% 14
2018
Q3
$626M Sell
14,201,360
-204,377
-1% -$9.01M 0.43% 10
2018
Q2
$523M Buy
14,405,737
+1,038,492
+8% +$37.7M 0.45% 9
2018
Q1
$474M Buy
13,367,245
+2,340,112
+21% +$83.1M 0.36% 20
2017
Q4
$399M Buy
11,027,133
+1,765,138
+19% +$63.9M 0.33% 31
2017
Q3
$331M Buy
9,261,995
+1,090,496
+13% +$38.9M 0.34% 18
2017
Q2
$274M Buy
8,171,499
+592,098
+8% +$19.9M 0.29% 24
2017
Q1
$259M Buy
7,579,401
+416,981
+6% +$14.3M 0.28% 26
2016
Q4
$233M Sell
7,162,420
-690,973
-9% -$22.4M 0.25% 24
2016
Q3
$266M Sell
7,853,393
-18,466
-0.2% -$625K 0.3% 17
2016
Q2
$277M Sell
7,871,859
-375,276
-5% -$13.2M 0.36% 15
2016
Q1
$239M Sell
8,247,135
-5,548,358
-40% -$161M 0.36% 16
2015
Q4
$441M Buy
13,795,493
+61,724
+0.4% +$1.98M 0.54% 8
2015
Q3
$426M Buy
13,733,769
+1,172,075
+9% +$36.3M 0.51% 7
2015
Q2
$415M Buy
12,561,694
+1,318,220
+12% +$43.5M 0.47% 8
2015
Q1
$382M Buy
11,243,474
+1,210,932
+12% +$41.2M 0.44% 9
2014
Q4
$311M Sell
10,032,542
-1,263,021
-11% -$39.2M 0.3% 22
2014
Q3
$328M Buy
11,295,563
+279,743
+3% +$8.11M 0.32% 21
2014
Q2
$319M Buy
11,015,820
+456,300
+4% +$13.2M 0.34% 23
2014
Q1
$338M Sell
10,559,520
-1,497,532
-12% -$47.9M 0.38% 20
2013
Q4
$362M Buy
12,057,052
+1,430,228
+13% +$42.9M 0.37% 20
2013
Q3
$298M Sell
10,626,824
-16,351,214
-61% -$458M 0.36% 17
2013
Q2
$756M Buy
+26,978,038
New +$756M 0.94% 5